Remyelination of the nonhuman primate spinal cord by transplantation of H-transferase transgenic adult pig olfactory ensheathing cells
Christine Radtke
Department of Neurology, Yale University School of Medicine, New Haven, 06516
Neuroscience Research Center, Veterans Affairs Medical Center, West Haven, 06516
CTR. Anatomy, Hannover Medical School, Hannover, Germany
Search for more papers by this authorYukinori Akiyama
Department of Neurology, Yale University School of Medicine, New Haven, 06516
Neuroscience Research Center, Veterans Affairs Medical Center, West Haven, 06516
Search for more papers by this authorJane Brokaw
Alexion Pharmaceuticals Inc., Cheshire, Connecticut, 06410
Search for more papers by this authorKaren L. Lankford
Department of Neurology, Yale University School of Medicine, New Haven, 06516
Neuroscience Research Center, Veterans Affairs Medical Center, West Haven, 06516
Search for more papers by this authorKonstantin Wewetzer
CTR. Anatomy, Hannover Medical School, Hannover, Germany
Search for more papers by this authorCorresponding Author
William L. Fodor
Alexion Pharmaceuticals Inc., Cheshire, Connecticut, 06410
Corresponding authors: Jeffery D. Kocsis, Ph.D., Yale University School of Medicine, Neuroscience Research Center (127A), VAMC, West Haven, CT 06516. E–mail: [email protected]; and William L. Fodor, Ph.D., University of Connecticut, Department of Molecular and Cellular Biology, CT Center for Regenerative Biology, Storrs, CT 06269. Eߝmail: [email protected]
Search for more papers by this authorCorresponding Author
Jeffery D. Kocsis
Department of Neurology, Yale University School of Medicine, New Haven, 06516
Neuroscience Research Center, Veterans Affairs Medical Center, West Haven, 06516
Corresponding authors: Jeffery D. Kocsis, Ph.D., Yale University School of Medicine, Neuroscience Research Center (127A), VAMC, West Haven, CT 06516. E–mail: [email protected]; and William L. Fodor, Ph.D., University of Connecticut, Department of Molecular and Cellular Biology, CT Center for Regenerative Biology, Storrs, CT 06269. Eߝmail: [email protected]
Search for more papers by this authorChristine Radtke
Department of Neurology, Yale University School of Medicine, New Haven, 06516
Neuroscience Research Center, Veterans Affairs Medical Center, West Haven, 06516
CTR. Anatomy, Hannover Medical School, Hannover, Germany
Search for more papers by this authorYukinori Akiyama
Department of Neurology, Yale University School of Medicine, New Haven, 06516
Neuroscience Research Center, Veterans Affairs Medical Center, West Haven, 06516
Search for more papers by this authorJane Brokaw
Alexion Pharmaceuticals Inc., Cheshire, Connecticut, 06410
Search for more papers by this authorKaren L. Lankford
Department of Neurology, Yale University School of Medicine, New Haven, 06516
Neuroscience Research Center, Veterans Affairs Medical Center, West Haven, 06516
Search for more papers by this authorKonstantin Wewetzer
CTR. Anatomy, Hannover Medical School, Hannover, Germany
Search for more papers by this authorCorresponding Author
William L. Fodor
Alexion Pharmaceuticals Inc., Cheshire, Connecticut, 06410
Corresponding authors: Jeffery D. Kocsis, Ph.D., Yale University School of Medicine, Neuroscience Research Center (127A), VAMC, West Haven, CT 06516. E–mail: [email protected]; and William L. Fodor, Ph.D., University of Connecticut, Department of Molecular and Cellular Biology, CT Center for Regenerative Biology, Storrs, CT 06269. Eߝmail: [email protected]
Search for more papers by this authorCorresponding Author
Jeffery D. Kocsis
Department of Neurology, Yale University School of Medicine, New Haven, 06516
Neuroscience Research Center, Veterans Affairs Medical Center, West Haven, 06516
Corresponding authors: Jeffery D. Kocsis, Ph.D., Yale University School of Medicine, Neuroscience Research Center (127A), VAMC, West Haven, CT 06516. E–mail: [email protected]; and William L. Fodor, Ph.D., University of Connecticut, Department of Molecular and Cellular Biology, CT Center for Regenerative Biology, Storrs, CT 06269. Eߝmail: [email protected]
Search for more papers by this authorAbstract
Olfactory ensheathing cells (OECs) have been shown to mediate remyelination and to stimulate axonal regeneration in a number of in vivo rodent spinal cord studies. However, whether OECs display similar properties in the primate model has not been tested so far. In the present study, we thus transplanted highly-purified OECs isolated from transgenic pigs expressing the α1,2 fucosyltransferase gene (H-transferase or HT) gene into a demyelinated lesion of the African green monkey spinal cord. Four weeks posttransplantation, robust remyelination was found in 62.5% of the lesion sites, whereas there was virtually no remyelination in the nontransplanted controls. This together with the immunohistochemical demonstration of the grafted cells within the lesioned area confirmed that remyelination was indeed achieved by OECs. Additional in vitro assays demonstrated l) that the applied cell suspension consisted of >98% OECs, 2) that the majority of the cells expressed the transgene, and 3) that expression of the HT gene reduced complement activation more than twofold compared with the nontransgenic control. This is the first demonstration that xenotransplantation of characterized OECs into the primate spinal cord results in remyelination.
Supporting Information
Filename | Description |
---|---|
fsb2fj030214fje-sup-0001.pdfPDF document, 175.6 KB | Supplementary Material |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Li, Y., Field, P. M., and Raisman, G. 1997 Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science 277, 2000–2002
- 2Ramon-Cueto, A., Plant, G. W., Avila, J., and Bunge, M. B. 1998 Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J. Neurosci. 18, 3803–3815
- 3Imaizumi, T., Lankford, K. L., and Kocsis, J. D. 2000 Transplantation of olfactory ensheathing cells or Schwann cells restores rapid and secure conduction across the transected spinal cord. Brain Res. 854, 70–78
- 4Imaizumi, T., Lankford, K. L., Burton, W. V., Fodor, W. L., and Kocsis, J. D. 2000 Xenotransplantation of transgenic pig olfactory ensheathing cells promotes axonal regeneration in rat spinal cord. Nat. Biotechno. 18, 949–953
- 5Franklin, R. J., Gilson, J. M., Franceschini, I. A., and Barnett, S. C. 1996 Schwann cell- like myelination following transplantation of an olfactory bulb-ensheathing cell line into areas of demyelination in the adult CNS. Glia 17, 217–224
10.1002/(SICI)1098-1136(199607)17:3<217::AID-GLIA4>3.0.CO;2-Y CASPubMedWeb of Science®Google Scholar
- 6Imaizumi, T., Lankford, K. L., Waxman, S. G., Greer, C. A., and Kocsis, J. D. 1998 Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord. J. Neurosci. 18, 6176–6185
- 7Li, Y., Field, P. M., and Raisman, G. 1998 Regeneration of adult rat corticospinal axons induced by transplanted olfactory ensheathing cells. J. Neurosci. 18, 10514–10524
- 8Lu, J., Feron, F., Mackay-Sim, A., and Waite, P. M. 2002 Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. Brain 125, 14–21
- 9Ramon-Cueto, A., Cordero, M. I., Santos-Benito, F. F., and Avila, J. 2000 Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 25, 425–435
- 10Fodor, W. L., Williams, B. L., Matis, L. A., Madri, J. A., Rollins, S. A., Knight, J. W., Velander, W., and Squinto, S. P. 1994 Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc. Natl. Acad. Sci. USA 91, 11153–11157
- 11Costa, C., Zhao, L., Burton, W. V., Bondioli, K. R., Williams, B. L., Hoagland, T. A., Ditullio, P. A., Ebert, K. M., and Fodor, W. L. 1999 Expression of the human alpha1,2- fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum-mediated cytolysis. FASEB J. 13, 1762–1773
- 12Costa, C., Zhao, L., Burton, W. V., Rosas, C., Bondioli, K. R., Williams, B. L., Hoagland, T. A., Dalmasso, A. P., and Fodor, W. L. 2002 Transgenic pigs designed to express human CD59 and H-transferase to avoid humoral xenograft rejection. Xenotransplantation 9, 45–57
- 13Chuah, M. I., and Au, C. 1991 Olfactory Schwann cells are derived from precursor cells in the olfactory epithelium. J. Neurosci. Res. 29, 172–180
- 14Fodor, W. L., Williams, B. L., Matis, L. A., Madri, J. A., Rollins, S. A., Knight, J. W., Velander, W., and Squinto, S. P. 1994 Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc. Natl. Acad. Sci. USA 91, 11153–11157
- 15Berthold, C. H. Morphology of normal peripheral axons. In Physiology and Pathobiology of Axons ( S. G. Waxman, ed) pp. 3–64, New York, Raven
- 16Ramon-Cueto, A., and Avila, J. 1998 Olfactory ensheathing glia: properties and function. Brain Res. Bul. 46, 175–187
- 17Smith, P. M., Lakatos, A., Barnett, S. C., Jeffery, N. D., and Franklin, R. J. 2002 Cryopreserved cells isolated from the adult canine olfactory bulb are capable of extensive remyelination following transplantation into the adult rat CNS. Exp. Neurol. 176, 402–406
- 18Isacson, O., Deacon, T. W., Pakzaban, P., Galpern, W. R., Dinsmore, J., and Burns, L. H. 1995 Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nat. Med. 1, 1189–1194
- 19Pixley, S. K. 1992 The olfactory nerve contains two populations of glia, identified both in vivo and in vitro. Glia 5, 269–284
- 20Galili, U., and Swanson, K. 1991 Gene sequences suggest inactivation of alpha-1,3- galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc. Natl. Acad. Sci. USA 88, 7401–7404
- 21Barnett, S. C., Alexander, C. L., Iwashita, Y., Gilson, J. M., Crowther, J., Clark, L., Dunn, L. T., Papanastassiou, V., Kennedy, P. G., and Franklin, R. J. 2000 Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons. Brain 123, 1581–1588
- 22Kato, T., Honmou, O., Uede, T., Hashi, K., and Kocsis, J. D. 2000 Transplantation of human olfactory ensheathing cells elicits remyelination of demyelinated rat spinal cord. Glia 30, 209–218
10.1002/(SICI)1098-1136(200005)30:3<209::AID-GLIA1>3.0.CO;2-8 CASPubMedWeb of Science®Google Scholar
- 23Wewetzer, K., Verdu, E., Angelov, D. N., and Navarro, X. 2002 Olfactory ensheathing glia and Schwann cells: two of a kind? Cell Tissue Res. 309, 337–345
- 24Takami, T., Oudega, M., Bates, M. L., Wood, P. M., Kleitmann, N., and Bunge, M. B. 2002 Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J. Neurosci. 22, 6670–6681
- 25Auchincloss, H.Jr., and Sachs, D. H. 1998 Xenogenic transplantation. Annu. Rev. Immunol. 16, 433–470
- 26McCurry, K. R., Parker, W., Cotterell, A. H., Weidner, B. C., Lin, S. S., Daniels, L. J., Holzknecht, Z. E., Byrne, G. W., Diamond, L. E., Logan, J. S., et al. 1997 Humoral responses to pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. Hum. Immunol. 58, 91–105
- 27Cicchetti, F., Fodor, W., Deacon, T. W., vanHorne, C., Rollins, S., Burton, W., Costantini, L. C., and Isacson, O. 2002 Immune parameters relevant to neural xenograft survival in the primate brain. Xenotransplantation 9, 1–9
- 28Deacon, T., Schumacher, J., Dinsmore, J., Thomas, C., Palmer, P., Kott, S., Edge, A., Penney, D., Kassissieh, S., Dempsey, P., et al. 1997 Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat. Med. 3, 350–353
- 29Chen, S. C., Mullon, C., Kahaku, E., Watanabe, F., Hewitt, W., Eguchi, S., Middleton, Y., Arkadopoulos, N., Rozga, J., Solomon, B., et al. 1997 Treatment of severe liver failure with a bioartificial liver. Ann. NY Acad. Sci. 831, 350–360
- 30Watanabe, E., Smith, D. M., Jr., Delcarpio, J. B., Sun, J., Smart, F. W., vanMeter, C. H.Jr., and Claycomb, W. C. 1998 Cardiomyocyte transplantation in a porcine myocardial infarction model. Cell Transplant. 7, 239–246